Pro Medicus (ASX:PME) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:PME Pro Medicus Ltd ASX:PME
97 GF Score
Price A$159.82
GF Value A$250.62
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Pro Medicus FFO per Share?

FFO per Share only applies to REITs.

ASX:PME
97GF Score
Pro Medicus Ltd ASX:PME
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pro Medicus (ASX:PME) Overvalued in 2026?

Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued. The current stock price of A$159.82 is trading 36.2% below its estimated GF Value™ of A$250.62. GuruFocus considers Pro Medicus to be Significantly Undervalued.

Key valuation signals for ASX:PME:

  • FFO per Share:
  • GF Value™: A$250.62 vs. price of A$159.82 (36.2% below fair value)
  • GF Score™: 97/100 with 1 warning sign

No single metric tells the full story. See the ASX:PME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pro Medicus Business Description

Address 450 Swan Street, Richmond, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
97GF Score

Get the complete analysis for ASX:PME

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$159.82
Price
A$250.62
GF Value